Boston Scientific Corp (BSX) Stock Price, Quote & News

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal sur...

Industry: Medical Devices

Sector: Healthcare

Phone: 508 683 4000

Website: www.bostonscientific.com

Address:

300 Boston Scientific Way, Marlborough, United States

LiquidThetaLEAPS Oct. 25 at 6:43 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BSX Current Share Price: $103.36 Contracts: $BSX December 18, 2026 $105 Calls Scale in: $11.90- $14.55 Scale out: $18.51-$23.80 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

humphreystone Oct. 24 at 10:31 PM

$BSX BSX - Riding on the gap up Volume: Neutral. Price Action: Broken downtrend, $94 support. Indicators: Ichimoku bullish, MACD & DMI bullish. StochRSI near overbought. Setup: Short/Long breakout. Possible reversal. Entries: $104, $100. Stop: $94. Targets: $109, $114, $120, $127, $139, $300.

0 · Reply

jewell69 Oct. 24 at 7:14 PM

$BSX THROWING GOOD MONEY AFTER BAD 10/24/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 40 $101.30 -$4.X,052.00 10/23/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 56 $103.10 -$5,773.60 TOOK PROFITS AT 104.33 ON 10/22

0 · Reply

jewell69 Oct. 24 at 5:23 PM

trying to throw good money after bad 40 at 101.30 now 101.47 x .49 10/24/25 1:21 pm edt $BSX recent buy 10/23/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 56 $103.10 -$5,773.60

0 · Reply

MoneyGroupLLC Oct. 24 at 4:46 PM

Enter: $BSX NOV 14 2025 $103 CALLS Buy in Price: $2.30 - $2.95 Take Profit: $4.16 Stop Bleeding: $2.60 ROI Potential: 41% https://moneygroup.us/

0 · Reply

justinaugustus Oct. 23 at 10:47 PM

$BSX I'm a sucker for an epic losing streak BSX is on an 8-session losing streak, its longest since late 2022. As a mean reversion trader, this suggests a buy opportunity. While a similar setup recently led to a long, frustrating trade, it was ultimately profitable. This time, I plan a quicker exit—I'll close on the first profitable close after today. Entry is at 98.37. This reflects my own view, not investment advice. Always do your own research and invest at your own risk.https://stocktwits.com/GaryBrown7417/message/632828520

0 · Reply

JarvisFlow Oct. 23 at 9:05 PM

UBS has adjusted their stance on Boston Scientific ( $BSX ), setting the rating to Buy with a target price of 135 → 140.

0 · Reply

jewell69 Oct. 23 at 7:12 PM

$BSX RE ENTRY 10/23/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 56 $103.10 -$5,773.60 10/22/2025 Sell Trade Details BSX BOSTON SCIENTIFIC CORP 55 $104.33 $0.01 $5,738.14 09/15/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 28 $102.03 -$2.X,856.84 09/12/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 27 $102.72 -$2.X,773.44

0 · Reply

jewell69 Oct. 23 at 3:45 PM

$BSX trying to re-enter 103.10 now 103.81 at 11:43 am edt. recent profit taken yesterday 10/22 as shown below 10/22/2025 Sell Trade Details BSX BOSTON SCIENTIFIC CORP 55 $104.33 $0.01 $5,738.14

0 · Reply

MoneyGroupLLC Oct. 23 at 3:13 PM

Enter: $BSX NOV 14 2025 $104 CALLS Buy in Price: $2.68 - $2.81 Take Profit: $6.32 Stop Bleeding: $2.36 ROI Potential: 136% Exit Within: 3 Weeks https://moneygroup.us/alerts

0 · Reply

Boston Scientific Q3: Operational Improvements Warrant An Upgrade To A Buy

Oct 23, 2025, 9:41 AM EDT - 1 day ago

These Analysts Increase Their Forecasts On Boston Scientific After Upbeat Earnings

Oct 22, 2025, 2:53 PM EDT - 2 days ago

Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript

Oct 22, 2025, 7:36 AM EDT - 3 days ago

Boston Scientific lifts annual profit forecast on strong demand for heart devices

Oct 22, 2025, 6:59 AM EDT - 3 days ago

Boston Scientific Raises Outlook on Continued Cardiovascular Growth

Oct 22, 2025, 6:30 AM EDT - 3 days ago

Boston Scientific announces results for third quarter 2025

Oct 21, 2025, 11:07 AM EDT - 3 days ago

It's time to scoop up undervalued stocks in this critical sector of the economy

ISRG SYK BDX BIO FEGE JGLO MDT

Oct 17, 2025, 7:09 AM EDT - 8 days ago

Boston Scientific buys Nalu Medical for $533 million

Oct 17, 2025, 7:00 AM EDT - 8 days ago

Boston Scientific Announces Agreement to Acquire Nalu Medical, Inc.

Oct 13, 2025, 2:53 PM EDT - 11 days ago

9 Stocks to Buy Before Their Earnings Reports

ADBE CSCO GM OKTA ZM

Oct 9, 2025, 5:00 AM EDT - 16 days ago

4 Top AI-Powered Healthcare Stocks

OPRX VEEV ZEPP

Sep 30, 2025, 6:12 PM EDT - 24 days ago

Boston Scientific Corporation (BSX) Analyst/Investor Day Transcript

Sep 19, 2025, 7:01 AM EDT - 5 weeks ago

Top 3 Health Care Stocks That May Explode In September

ATYR RVPH

Sep 2, 2025, 8:00 AM EDT - 7 weeks ago

Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results

Aug 25, 2025, 2:26 PM EDT - 2 months ago

8 Growth Stocks to Buy That Aren't Technology. What Makes Them Worth It.

COF UBER

Aug 9, 2025, 8:53 AM EDT - 2 months ago

Boston Scientific Corporation Is Expensive But Worth It

Aug 7, 2025, 9:45 PM EDT - 2 months ago

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

ACLX EW EXAS GH ISRG LLY MASI

Aug 6, 2025, 8:07 AM EDT - 2 months ago

Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions

Jul 31, 2025, 9:52 AM EDT - 3 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

CAH DXCM EW ISRG LLY PODD SYK

Jul 23, 2025, 12:10 PM EDT - 3 months ago

Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript

Jul 23, 2025, 10:46 AM EDT - 3 months ago

Cramer's Stop Trading: Boston Scientific

Jul 23, 2025, 7:58 AM EDT - 3 months ago

Boston Scientific lifts annual profit view on steady heart devices demand

Jul 23, 2025, 6:30 AM EDT - 3 months ago

Boston Scientific announces results for second quarter 2025

Jul 22, 2025, 11:00 AM EDT - 3 months ago

How To Trade Boston Scientific Stock Ahead Of Its Upcoming Earnings?

Jul 11, 2025, 5:05 AM EDT - 3 months ago

North America Ureteroscopes Market Outlook Report 2018-2033 with an Overview of Key Companies - Boston Scientific, KARL STORZ, Olympus, PENTAX Medical, and Richard Wolf

Jul 7, 2025, 7:00 AM EDT - 3 months ago

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

Jul 1, 2025, 8:00 AM EDT - 4 months ago

Boston Scientific announces conference call discussing second quarter 2025 results

Jun 17, 2025, 8:00 AM EDT - 4 months ago

I'm Buying Dividend Aristocrats At Bargain Basement Prices

JNJ KO MDT PEP

Jun 16, 2025, 11:00 AM EDT - 4 months ago

What's Happening With Boston Scientific Stock?

Jun 10, 2025, 10:53 AM EDT - 4 months ago

20 stocks bucking bad trends on Wall Street — what might be next for them?

AMT ANET AVGO TRMB BAC C CCL

Jun 6, 2025, 2:42 PM EDT - 5 months ago

3 Growth Stocks That Aren't the Magnificent 7

CYBR

May 30, 2025, 4:45 AM EDT - 5 months ago

Boston Scientific: Old, Reliable; Buy For Their Consistent Growth

May 28, 2025, 3:40 PM EDT - 5 months ago

Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook

May 28, 2025, 12:14 PM EDT - 5 months ago

Boston Scientific Corporation (BSX) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

May 28, 2025, 8:09 AM EDT - 5 months ago

Boston Scientific to not seek US approval for heart device amid regulatory challenges

May 13, 2025, 3:33 PM EDT - 5 months ago

Boston Scientific Corporation (BSX) Bank of America's 2025 Health Care Conference (Transcript)

May 1, 2025, 8:00 AM EDT - 6 months ago

Boston Scientific announces upcoming investor conference schedule

Apr 29, 2025, 11:30 AM EDT - 6 months ago

Baron Health Care Fund Q1 2025 Top Contributors And Detractors

ACLX DHR GKOS INSM ISRG LLY RDNT

Apr 24, 2025, 3:41 PM EDT - 6 months ago

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

Apr 24, 2025, 2:13 PM EDT - 6 months ago

Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results

Apr 23, 2025, 11:34 AM EDT - 6 months ago

Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript

Apr 23, 2025, 10:22 AM EDT - 6 months ago

Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition

Apr 23, 2025, 9:56 AM EDT - 6 months ago

Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire

Apr 23, 2025, 8:11 AM EDT - 6 months ago

Boston Scientific raises 2025 profit forecast on strong heart device sales

Apr 23, 2025, 6:45 AM EDT - 6 months ago

Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan

Apr 23, 2025, 6:30 AM EDT - 6 months ago

Boston Scientific announces results for first quarter 2025

Apr 1, 2025, 4:35 PM EDT - 7 months ago

Goldman Sachs Thinks These Stocks Are ‘Insulated' From a Trade War

PCG

Apr 1, 2025, 8:00 AM EDT - 7 months ago

Boston Scientific announces conference call discussing first quarter 2025 results

Mar 4, 2025, 1:00 PM EST - 8 months ago

Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript)

Mar 3, 2025, 6:58 AM EST - 8 months ago

Boston Scientific announces agreement to acquire SoniVie Ltd.

LiquidThetaLEAPS Oct. 25 at 6:43 AM

0 · Reply

humphreystone Oct. 24 at 10:31 PM

0 · Reply

jewell69 Oct. 24 at 7:14 PM

0 · Reply

jewell69 Oct. 24 at 5:23 PM

trying to throw good money after bad 40 at 101.30 now 101.47 x .49 10/24/25 1:21 pm edt $BSX recent buy 10/23/2025 Buy Trade Details BSX BOSTON SCIENTIFIC CORP 56 $103.10 -$5,773.60

0 · Reply

MoneyGroupLLC Oct. 24 at 4:46 PM

Enter: $BSX NOV 14 2025 $103 CALLS Buy in Price: $2.30 - $2.95 Take Profit: $4.16 Stop Bleeding: $2.60 ROI Potential: 41% https://moneygroup.us/

0 · Reply

justinaugustus Oct. 23 at 10:47 PM

0 · Reply

JarvisFlow Oct. 23 at 9:05 PM

UBS has adjusted their stance on Boston Scientific ( $BSX ), setting the rating to Buy with a target price of 135 → 140.

0 · Reply

jewell69 Oct. 23 at 7:12 PM

0 · Reply

jewell69 Oct. 23 at 3:45 PM

$BSX trying to re-enter 103.10 now 103.81 at 11:43 am edt. recent profit taken yesterday 10/22 as shown below 10/22/2025 Sell Trade Details BSX BOSTON SCIENTIFIC CORP 55 $104.33 $0.01 $5,738.14

0 · Reply

MoneyGroupLLC Oct. 23 at 3:13 PM

Enter: $BSX NOV 14 2025 $104 CALLS Buy in Price: $2.68 - $2.81 Take Profit: $6.32 Stop Bleeding: $2.36 ROI Potential: 136% Exit Within: 3 Weeks https://moneygroup.us/alerts

0 · Reply

erevnon Oct. 23 at 2:56 PM

Morgan Stanley maintains Boston Scientific $BSX at Overweight and raises the price target from $125 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

JarvisFlow Oct. 23 at 2:32 PM

Truist Securities has updated their rating for Boston Scientific ( $BSX ) to Buy with a price target of 130.

0 · Reply

JarvisFlow Oct. 23 at 1:18 PM

Wells Fargo updates rating for Boston Scientific ( $BSX ) to Overweight, target set at 124 → 125.

0 · Reply

JarvisFlow Oct. 23 at 1:13 PM

Morgan Stanley has adjusted their stance on Boston Scientific ( $BSX ), setting the rating to Overweight with a target price of 125 → 130.

0 · Reply

JarvisFlow Oct. 23 at 1:02 PM

Canaccord Genuity updates rating for Boston Scientific ( $BSX ) to Buy, target set at 132.

0 · Reply

TheVulcanDevilWhale Oct. 23 at 2:57 AM

$BSX

0 · Reply

MoneyGroupLLC Oct. 22 at 10:35 PM

Enter: $BSX NOV 14 2025 $104 CALLS Buy in Price: $2.80 - $3.10 Take Profit: $4.00 Stop Bleeding: $2.73 ROI Potential: 29% Exit Within: 3 Weeks https://moneygroup.us/alerts

0 · Reply

topstockalerts Oct. 22 at 7:15 PM

$BSX strong watch for today..

0 · Reply

lecorb Oct. 22 at 7:01 PM

$BSX Boston Scientific raises 2025 organic growth guidance to 15.5% amid WATCHMAN and EP momentum https://seekingalpha.com/news/4507045-boston-scientific-raises-2025-organic-growth-guidance-to-15_5-percent-amid-watchman-and-ep?mailingid=42119184&messageid=2900&position=rta_news_most_popular_main_2_textlink&serial=42119184.774&source=email_2900&utm_campaign=rta-stock-news&utm_content=link-3&utm_medium=email&utm_source=seeking_alpha&utm_term=42119184.774

0 · Reply

ZacksResearch Oct. 22 at 6:49 PM

$BSX Q3 earnings beat — but is it enough to fuel a rally? 🤔 🔹 Adjusted EPS of 75 cents, up 19% year over year, surpasses estimates by 5.6%. 🔹 Revenue climbed 20.3% year over year on a reported basis, beating expectations with strong growth across segments. Optimistic full-year outlook update — discover the details here 👉 https://www.zacks.com/stock/news/2773960/boston-scientific-beats-on-q3-earnings-raises-2025-view-stock-up?cid=sm-stocktwits-2-2773960-body-17200&ADID=SYND_STOCKTWITS_TWEET_2_2773960_BODY_17200

0 · Reply

topstockalerts Oct. 22 at 5:59 PM

$BSX showing high relative strength..

0 · Reply

ZacksResearch Oct. 22 at 5:49 PM

$BSX just delivered a clean beat and raised guidance — classic strength move. Q3 EPS jumped 19%, and management boosted its 2025 sales and EPS outlook — that’s confidence backed by performance. Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2773960/boston-scientific-beats-on-q3-earnings-raises-2025-view-stock-up?cid=sm-stocktwits-2-2773960-teaser-17196&ADID=SYND_STOCKTWITS_TWEET_2_2773960_TEASER_17196

0 · Reply

Market Cap	151.72B
Revenue (ttm)	16.75B
Net Income (ttm)	1.85B
EPS (ttm)	N/A
PE Ratio	35.20
Forward PE	34.22
Profit Margin	11.07%
Debt to Equity Ratio	0.51

Volume	6,798,300
Avg Vol	9,324,410
Day's Range	N/A - N/A
Shares Out	1.48B
Stochastic %K	60%
Beta	0.61
Analysts	Strong Sell
Price Target	$126.26